Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Tax Provisions: 2017-2025

  • Fortress Biotech's Tax Provisions fell 74.00% to $26,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $841,000, marking a year-over-year decrease of 21.33%. This contributed to the annual value of $312,000 for FY2024, which is 40.12% down from last year.
  • According to the latest figures from Q3 2025, Fortress Biotech's Tax Provisions is $26,000, which was down 92.26% from $336,000 recorded in Q4 2024.
  • Fortress Biotech's 5-year Tax Provisions high stood at $500,000 for Q4 2021, and its period low was $26,000 during Q3 2025.
  • Moreover, its 3-year median value for Tax Provisions was $141,000 (2023), whereas its average is $196,400.
  • Data for Fortress Biotech's Tax Provisions shows a maximum YoY plummeted of 74.00% (in 2025) over the last 5 years.
  • Quarterly analysis of 5 years shows Fortress Biotech's Tax Provisions stood at $500,000 in 2021, then decreased by 10.20% to $449,000 in 2022, then fell by 15.59% to $379,000 in 2023, then dropped by 11.35% to $336,000 in 2024, then plummeted by 74.00% to $26,000 in 2025.
  • Its Tax Provisions was $26,000 in Q3 2025, compared to $336,000 in Q4 2024 and $100,000 in Q3 2024.